PMID- 36058634 OWN - NLM STAT- MEDLINE DCOM- 20221214 LR - 20230315 IS - 2190-6009 (Electronic) IS - 2190-5991 (Print) IS - 2190-5991 (Linking) VI - 13 IP - 6 DP - 2022 Dec TI - Human adaptation to immobilization: Novel insights of impacts on glucose disposal and fuel utilization. PG - 2999-3013 LID - 10.1002/jcsm.13075 [doi] AB - BACKGROUND: Bed rest (BR) reduces whole-body insulin-stimulated glucose disposal (GD) and alters muscle fuel metabolism, but little is known about metabolic adaptation from acute to chronic BR nor the mechanisms involved, particularly when volunteers are maintained in energy balance. METHODS: Healthy males (n = 10, 24.0 +/- 1.3 years), maintained in energy balance, underwent 3-day BR (acute BR). A second cohort matched for sex and body mass index (n = 20, 34.2 +/- 1.8 years) underwent 56-day BR (chronic BR). A hyperinsulinaemic euglycaemic clamp (60 mU/m(2) /min) was performed to determine rates of whole-body insulin-stimulated GD before and after BR (normalized to lean body mass). Indirect calorimetry was performed before and during steady state of each clamp to calculate rates of whole-body fuel oxidation. Muscle biopsies were taken to determine muscle glycogen, metabolite and intramyocellular lipid (IMCL) contents, and the expression of 191 mRNA targets before and after BR. Two-way repeated measures analysis of variance was used to detect differences in endpoint measures. RESULTS: Acute BR reduced insulin-mediated GD (Pre 11.5 +/- 0.7 vs. Post 9.3 +/- 0.6 mg/kg/min, P < 0.001), which was unchanged in magnitude following chronic BR (Pre 10.2 +/- 0.4 vs. Post 7.9 +/- 0.3 mg/kg/min, P < 0.05). This reduction in GD was paralleled by the elimination of the 35% increase in insulin-stimulated muscle glycogen storage following both acute and chronic BR. Acute BR had no impact on insulin-stimulated carbohydrate (CHO; Pre 3.69 +/- 0.39 vs. Post 4.34 +/- 0.22 mg/kg/min) and lipid (Pre 1.13 +/- 0.14 vs. Post 0.59 +/- 0.11 mg/kg/min) oxidation, but chronic BR reduced CHO oxidation (Pre 3.34 +/- 0.18 vs. Post 2.72 +/- 0.13 mg/kg/min, P < 0.05) and blunted the magnitude of insulin-mediated inhibition of lipid oxidation (Pre 0.60 +/- 0.07 vs. Post 0.85 +/- 0.06 mg/kg/min, P < 0.05). Neither acute nor chronic BR increased muscle IMCL content. Plentiful mRNA abundance changes were detected following acute BR, which waned following chronic BR and reflected changes in fuel oxidation and muscle glycogen storage at this time point. CONCLUSIONS: Acute BR suppressed insulin-stimulated GD and storage, but the extent of this suppression increased no further in chronic BR. However, insulin-mediated inhibition of fat oxidation after chronic BR was less than acute BR and was accompanied by blunted CHO oxidation. The juxtaposition of these responses shows that the regulation of GD and storage can be dissociated from substrate oxidation. Additionally, the shift in substrate oxidation after chronic BR was not explained by IMCL accumulation but reflected by muscle mRNA and pyruvate dehydrogenase kinase 4 protein abundance changes, pointing to lack of muscle contraction per se as the primary signal for muscle adaptation. CI - (c) 2022 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders. FAU - Shur, Natalie F AU - Shur NF AUID- ORCID: 0000-0002-6622-2525 AD - Centre for Sport, Exercise and Osteoarthritis Research Versus Arthritis, School of Life Sciences, The University of Nottingham, Nottingham, UK. AD - National Institute for Health and Care Research (NIHR) Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, UK. FAU - Simpson, Elizabeth J AU - Simpson EJ AD - National Institute for Health and Care Research (NIHR) Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, UK. AD - MRC/Versus Arthritis Centre for Musculoskeletal Ageing Research, Schools of Life Sciences and Medicine, University of Nottingham, Nottingham, UK. FAU - Crossland, Hannah AU - Crossland H AD - National Institute for Health and Care Research (NIHR) Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, UK. AD - MRC/Versus Arthritis Centre for Musculoskeletal Ageing Research, Schools of Life Sciences and Medicine, University of Nottingham, Nottingham, UK. FAU - Chivaka, Prince K AU - Chivaka PK AD - Centre for Sport, Exercise and Osteoarthritis Research Versus Arthritis, School of Life Sciences, The University of Nottingham, Nottingham, UK. FAU - Constantin, Despina AU - Constantin D AD - National Institute for Health and Care Research (NIHR) Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, UK. AD - MRC/Versus Arthritis Centre for Musculoskeletal Ageing Research, Schools of Life Sciences and Medicine, University of Nottingham, Nottingham, UK. FAU - Cordon, Sally M AU - Cordon SM AD - MRC/Versus Arthritis Centre for Musculoskeletal Ageing Research, Schools of Life Sciences and Medicine, University of Nottingham, Nottingham, UK. FAU - Constantin-Teodosiu, Dumitru AU - Constantin-Teodosiu D AD - MRC/Versus Arthritis Centre for Musculoskeletal Ageing Research, Schools of Life Sciences and Medicine, University of Nottingham, Nottingham, UK. FAU - Stephens, Francis B AU - Stephens FB AD - Sport and Health Sciences, The University of Exeter, Exeter, UK. FAU - Lobo, Dileep N AU - Lobo DN AD - National Institute for Health and Care Research (NIHR) Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, UK. AD - MRC/Versus Arthritis Centre for Musculoskeletal Ageing Research, Schools of Life Sciences and Medicine, University of Nottingham, Nottingham, UK. FAU - Szewczyk, Nate AU - Szewczyk N AD - National Institute for Health and Care Research (NIHR) Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, UK. AD - MRC/Versus Arthritis Centre for Musculoskeletal Ageing Research, Schools of Life Sciences and Medicine, University of Nottingham, Nottingham, UK. AD - Ohio Musculoskeletal and Neurological Institute, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, USA. FAU - Narici, Marco AU - Narici M AD - MRC/Versus Arthritis Centre for Musculoskeletal Ageing Research, Schools of Life Sciences and Medicine, University of Nottingham, Nottingham, UK. AD - Department of Biomedical Sciences, University of Padua, Padua, Italy. FAU - Prats, Clara AU - Prats C AD - Core Facility for Integrated Microscopy, The University of Copenhagen, Copenhagen, Denmark. FAU - Macdonald, Ian A AU - Macdonald IA AD - National Institute for Health and Care Research (NIHR) Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, UK. AD - MRC/Versus Arthritis Centre for Musculoskeletal Ageing Research, Schools of Life Sciences and Medicine, University of Nottingham, Nottingham, UK. FAU - Greenhaff, Paul L AU - Greenhaff PL AD - Centre for Sport, Exercise and Osteoarthritis Research Versus Arthritis, School of Life Sciences, The University of Nottingham, Nottingham, UK. AD - National Institute for Health and Care Research (NIHR) Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, UK. AD - MRC/Versus Arthritis Centre for Musculoskeletal Ageing Research, Schools of Life Sciences and Medicine, University of Nottingham, Nottingham, UK. LA - eng GR - MR/P021220/1/MRC_/Medical Research Council/United Kingdom GR - BB/P005004/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom GR - DH_/Department of Health/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220904 PL - Germany TA - J Cachexia Sarcopenia Muscle JT - Journal of cachexia, sarcopenia and muscle JID - 101552883 RN - IY9XDZ35W2 (Glucose) RN - 0 (Insulin) RN - 9005-79-2 (Glycogen) RN - 0 (RNA, Messenger) RN - 0 (Lipids) SB - IM MH - Male MH - Humans MH - *Glucose/metabolism MH - *Muscle, Skeletal/metabolism MH - Insulin/metabolism MH - Glycogen/metabolism MH - RNA, Messenger/metabolism MH - Lipids PMC - PMC9745545 OTO - NOTNLM OT - bed rest OT - fuel oxidation OT - insulin resistance OT - muscle metabolism COIS- None declared. EDAT- 2022/09/05 06:00 MHDA- 2022/12/15 06:00 PMCR- 2022/12/01 CRDT- 2022/09/04 21:32 PHST- 2022/06/21 00:00 [revised] PHST- 2021/09/09 00:00 [received] PHST- 2022/08/14 00:00 [accepted] PHST- 2022/09/05 06:00 [pubmed] PHST- 2022/12/15 06:00 [medline] PHST- 2022/09/04 21:32 [entrez] PHST- 2022/12/01 00:00 [pmc-release] AID - JCSM13075 [pii] AID - 10.1002/jcsm.13075 [doi] PST - ppublish SO - J Cachexia Sarcopenia Muscle. 2022 Dec;13(6):2999-3013. doi: 10.1002/jcsm.13075. Epub 2022 Sep 4.